independent clinical initiative services limited

Live MatureMicroDeclining

independent clinical initiative services limited Company Information

Share INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED

Company Number

04786095

Shareholders

resicare alliance holdings limited

Group Structure

View All

Industry

Other human health activities

 

Registered Address

147 stamford hill, london, N16 5LG

independent clinical initiative services limited Estimated Valuation

£121.4k

Pomanda estimates the enterprise value of INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED at £121.4k based on a Turnover of £230.9k and 0.53x industry multiple (adjusted for size and gross margin).

independent clinical initiative services limited Estimated Valuation

£7.7k

Pomanda estimates the enterprise value of INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED at £7.7k based on an EBITDA of £2k and a 3.88x industry multiple (adjusted for size and gross margin).

independent clinical initiative services limited Estimated Valuation

£366.7k

Pomanda estimates the enterprise value of INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED at £366.7k based on Net Assets of £149.2k and 2.46x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Independent Clinical Initiative Services Limited Overview

Independent Clinical Initiative Services Limited is a live company located in london, N16 5LG with a Companies House number of 04786095. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2003, it's largest shareholder is resicare alliance holdings limited with a 100% stake. Independent Clinical Initiative Services Limited is a mature, micro sized company, Pomanda has estimated its turnover at £230.9k with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Independent Clinical Initiative Services Limited Health Check

Pomanda's financial health check has awarded Independent Clinical Initiative Services Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

1 Strong

positive_score

2 Regular

positive_score

8 Weak

size

Size

annual sales of £230.9k, make it smaller than the average company (£727.3k)

£230.9k - Independent Clinical Initiative Services Limited

£727.3k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -15%, show it is growing at a slower rate (7.2%)

-15% - Independent Clinical Initiative Services Limited

7.2% - Industry AVG

production

Production

with a gross margin of 38.5%, this company has a comparable cost of product (38.5%)

38.5% - Independent Clinical Initiative Services Limited

38.5% - Industry AVG

profitability

Profitability

an operating margin of -3.4% make it less profitable than the average company (5%)

-3.4% - Independent Clinical Initiative Services Limited

5% - Industry AVG

employees

Employees

with 4 employees, this is below the industry average (19)

4 - Independent Clinical Initiative Services Limited

19 - Industry AVG

paystructure

Pay Structure

on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)

£26.5k - Independent Clinical Initiative Services Limited

£26.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £57.7k, this is more efficient (£45.5k)

£57.7k - Independent Clinical Initiative Services Limited

£45.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 40 days, this is later than average (20 days)

40 days - Independent Clinical Initiative Services Limited

20 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 4 days, this is quicker than average (18 days)

4 days - Independent Clinical Initiative Services Limited

18 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Independent Clinical Initiative Services Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 97 weeks, this is less cash available to meet short term requirements (127 weeks)

97 weeks - Independent Clinical Initiative Services Limited

127 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 46.3%, this is a higher level of debt than the average (22.3%)

46.3% - Independent Clinical Initiative Services Limited

22.3% - Industry AVG

INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED financials

EXPORTms excel logo

Independent Clinical Initiative Services Limited's latest turnover from March 2024 is estimated at £230.9 thousand and the company has net assets of £149.2 thousand. According to their latest financial statements, Independent Clinical Initiative Services Limited has 4 employees and maintains cash reserves of £234.5 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover230,858426,880499,269378,699330,881526,615252,704246,255326,6161,259,245817,2651,175,781534,865845,372810,838
Other Income Or Grants000000000000000
Cost Of Sales141,980266,836317,963249,127211,673343,012159,663150,800204,123784,796507,786709,759308,359475,394460,706
Gross Profit88,878160,044181,306129,572119,208183,60393,04195,454122,493474,449309,478466,022226,507369,978350,131
Admin Expenses96,806161,151174,529174,827108,759145,56933,673111,290118,200461,010307,985461,456225,803377,901217,285
Operating Profit-7,928-1,1076,777-45,25510,44938,03459,368-15,8364,29313,4391,4934,566704-7,923132,846
Interest Payable00000001920000000
Interest Receivable9,9446,0229771571501,001611236463409459498459449232
Pre-Tax Profit2,0164,9157,754-45,09810,59939,03559,979-15,6194,73613,8481,9525,0641,164-7,474133,078
Tax-504-934-1,4730-2,014-7,417-11,3960-947-2,908-449-1,215-3030-37,262
Profit After Tax1,5123,9816,281-45,0988,58531,61848,583-15,6193,78910,9401,5033,849861-7,47495,816
Dividends Paid000000000000000
Retained Profit1,5123,9816,281-45,0988,58531,61848,583-15,6193,78910,9401,5033,849861-7,47495,816
Employee Costs105,941100,34895,61392,66690,67889,03785,90564,03263,436742,361476,289689,095319,823481,265469,033
Number Of Employees444444433342232152323
EBITDA*1,9849,33415,727-36,86916,34044,79166,653-7,68212,17020,3176,3598,9695,487-4,731135,490

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets16,13124,69717,45318,18820,65614,6029,49412,21318,92525,29514,2708,63110,6117,3966,939
Intangible Assets000000000000000
Investments & Other000000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets16,13124,69717,45318,18820,65614,6029,49412,21318,92525,29514,2708,63110,6117,3966,939
Stock & work in progress000000000000000
Trade Debtors25,92268,40978,95853,06347,50586,86035,99735,79550,58478,16146,59161,13826,79852,45255,503
Group Debtors000000000000000
Misc Debtors1,4802,0531,9961,6802,35056,4309,0652,1271,562000000
Cash234,516144,313139,083121,413192,073108,254158,62085,771103,05182,23581,367102,41096,90386,82292,684
misc current assets000000000000000
total current assets261,918214,775220,037176,156241,928251,544203,682123,693155,197160,396127,958163,548123,701139,274148,187
total assets278,049239,472237,490194,344262,584266,146213,176135,906174,122185,691142,228172,179134,312146,670155,126
Bank overdraft00000000615000000
Bank loan000000000000000
Trade Creditors 1,6027,3461,2153778038,0228291,31539675,33145,07777,73843,42057,41558,627
Group/Directors Accounts2,9872001,633000000000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities120,20078,03786,54853,05875,71881,67668,29338,58160,183000000
total current liabilities124,78985,58389,39653,43576,52189,69869,12239,89661,19475,33145,07777,73843,42057,41558,627
loans000000000000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities000000000000000
provisions4,0336,1744,3603,4563,5122,4821,7062,2453,5444,7652,4961,2891,589813583
total long term liabilities4,0336,1744,3603,4563,5122,4821,7062,2453,5444,7652,4961,2891,589813583
total liabilities128,82291,75793,75656,89180,03392,18070,82842,14164,73880,09647,57379,02745,00958,22859,210
net assets149,227147,715143,734137,453182,551173,966142,34893,765109,384105,59594,65593,15289,30388,44295,916
total shareholders funds149,227147,715143,734137,453182,551173,966142,34893,765109,384105,59594,65593,15289,30388,44295,916
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-7,928-1,1076,777-45,25510,44938,03459,368-15,8364,29313,4391,4934,566704-7,923132,846
Depreciation9,91210,4418,9508,3865,8916,7577,2858,1547,8776,8784,8664,4034,7833,1922,644
Amortisation000000000000000
Tax-504-934-1,4730-2,014-7,417-11,3960-947-2,908-449-1,215-3030-37,262
Stock000000000000000
Debtors-43,060-10,49226,2114,888-93,43598,2287,140-14,224-26,01531,570-14,54734,340-25,654-3,05155,503
Creditors-5,7446,131838-426-7,2197,193-486919-74,93530,254-32,66134,318-13,995-1,21258,627
Accruals and Deferred Income42,163-8,51133,490-22,660-5,95813,38329,712-21,60260,183000000
Deferred Taxes & Provisions-2,1411,814904-561,030776-539-1,299-1,2212,2691,207-300776230583
Cash flow from operations78,81818,32623,275-64,89995,614-39,50276,804-15,44021,26518,362-10,9977,43217,619-2,662101,935
Investing Activities
capital expenditure-1,346-17,685-8,215-5,918-11,945-11,865-4,566-1,442-1,507-17,903-10,505-2,423-7,998-3,649-9,583
Change in Investments000000000000000
cash flow from investments-1,346-17,685-8,215-5,918-11,945-11,865-4,566-1,442-1,507-17,903-10,505-2,423-7,998-3,649-9,583
Financing Activities
Bank loans000000000000000
Group/Directors Accounts2,787-1,4331,633000000000000
Other Short Term Loans 000000000000000
Long term loans000000000000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities000000000000000
share issue00000000000000100
interest9,9446,0229771571501,001611217443409459498459449232
cash flow from financing12,7314,5892,6101571501,001611217443409459498459449332
cash and cash equivalents
cash90,2035,23017,670-70,66083,819-50,36672,849-17,28020,816868-21,0435,50710,081-5,86292,684
overdraft0000000-615615000000
change in cash90,2035,23017,670-70,66083,819-50,36672,849-16,66520,201868-21,0435,50710,081-5,86292,684

independent clinical initiative services limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for independent clinical initiative services limited. Get real-time insights into independent clinical initiative services limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Independent Clinical Initiative Services Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for independent clinical initiative services limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in N16 area or any other competitors across 12 key performance metrics.

independent clinical initiative services limited Ownership

INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED group structure

Independent Clinical Initiative Services Limited has no subsidiary companies.

Ultimate parent company

1 parent

INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED

04786095

INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED Shareholders

resicare alliance holdings limited 100%

independent clinical initiative services limited directors

Independent Clinical Initiative Services Limited currently has 2 directors. The longest serving directors include Mr Nathan Schreiber (Jun 2024) and Mr Mayer Chersky (Jun 2024).

officercountryagestartendrole
Mr Nathan SchreiberEngland33 years Jun 2024- Director
Mr Mayer CherskyEngland35 years Jun 2024- Director

P&L

March 2024

turnover

230.9k

-46%

operating profit

-7.9k

0%

gross margin

38.5%

+2.69%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

149.2k

+0.01%

total assets

278k

+0.16%

cash

234.5k

+0.63%

net assets

Total assets minus all liabilities

independent clinical initiative services limited company details

company number

04786095

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

June 2003

age

22

incorporated

UK

ultimate parent company

accounts

Total Exemption Full

last accounts submitted

March 2024

previous names

N/A

accountant

-

auditor

-

address

147 stamford hill, london, N16 5LG

Bank

HSBC BANK PLC

Legal Advisor

-

independent clinical initiative services limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to independent clinical initiative services limited.

independent clinical initiative services limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for INDEPENDENT CLINICAL INITIATIVE SERVICES LIMITED. This can take several minutes, an email will notify you when this has completed.

independent clinical initiative services limited Companies House Filings - See Documents

datedescriptionview/download